Kolon Life Science Inc (102940) — Cash Flow Reinvestment Rate

Latest as of September 2025: 4.34x

Kolon Life Science Inc (102940) has a Cash Flow Reinvestment Rate of 4.34x as of September 2025, reinvesting ₩11.20 Billion (capex ₩8.05 Billion plus investments ₩-3.15 Billion) from operating cash flow of ₩2.58 Billion. Explore Kolon Life Science Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

4.34x
(Capex + Investments) / Operating CF

Total Reinvested

₩11.20 Billion
Capex + Investments

Operating Cash Flow

₩2.58 Billion
KRW

Capital Expenditures

₩8.05 Billion
KRW

Kolon Life Science Inc Cash Flow Reinvestment Rate (2011–2016)

Historical reinvestment intensity for Kolon Life Science Inc across 5 annual periods. Also explore total assets of Kolon Life Science Inc for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Kolon Life Science Inc (2011–2016)

Year-by-year capital reinvestment analysis for Kolon Life Science Inc. For live market cap and broader valuation context, see Kolon Life Science Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2016 1.46x ₩41.03 Billion ₩28.11 Billion ₩16.14 Billion ▼ -24.3%
2015 1.93x ₩40.11 Billion ₩20.81 Billion ₩15.22 Billion ▼ -7.7%
2014 2.09x ₩25.26 Billion ₩12.10 Billion ₩15.01 Billion ▼ -24.9%
2012 2.78x ₩64.96 Billion ₩23.37 Billion ₩61.01 Billion ▲ +2.9%
2011 2.70x ₩31.47 Billion ₩11.65 Billion ₩27.52 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow